Depression’s “Energy Crisis”: Fatigue Starts at the Cellular Level
Summary: Fatigue is one of the most debilitating and hardest-to-treat symptoms of major depressive disorder (MDD). New research…
New review calls for biologically grounded approach to psychiatric diagnosis
A comprehensive invited review published today in Brain Medicine confronts one of the most persistent paradoxes in modern…
Short-duration psychedelic therapy shows promise for major depression treatment
A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation…
Research reveals dual impact of brain stimulation on people with depression and anxiety
Research investigating the effects of transcranial direct current stimulation (tDCS) on individuals with depression and comorbid anxiety reveals…
Improving survival in people with severe psychiatric disorders
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
What influencers and critics aren’t telling you about antidepressants
On social media, influencers tout them as lifestyle medications that can turn around your life. But Health Secretary…
Genetic inflammatory signature defines depression subtypes and treatment response
Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that…
Harnessing AI tools for better treatment of serious mental illnesses
Serious mental illnesses (SMI) take a tremendous toll on individuals, their friends and family, and society as a…
DNA test boosts recovery in treatment-resistant depression
A major new meta-analysis shows that a DNA test guiding antidepressant choice boosts recovery odds in treatment-resistant depression,…